[{"address1": "828 Winter Street", "address2": "Suite 300", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 524 2466", "website": "https://xiliotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 73, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rene  Russo BCPS, Pharm.D.", "age": 49, "title": "President, CEO & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 875130, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Frankenfield", "age": 42, "title": "Chief Operating Officer", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 704848, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Katarina  Luptakova M.D.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 591917, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin M. Brennan", "age": 54, "title": "Senior VP of Finance & Accounting", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Uli  Bialucha Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Hensley", "title": "Chief Legal Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott  Coleman Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.06, "open": 1.06, "dayLow": 0.95, "dayHigh": 1.06, "regularMarketPreviousClose": 1.06, "regularMarketOpen": 1.06, "regularMarketDayLow": 0.9548, "regularMarketDayHigh": 1.06, "payoutRatio": 0.0, "beta": -0.263, "forwardPE": -1.670345, "volume": 2944064, "regularMarketVolume": 2944064, "averageVolume": 3999077, "averageVolume10days": 20841690, "averageDailyVolume10Day": 20841690, "bid": 0.9307, "ask": 0.9829, "bidSize": 5, "askSize": 8, "marketCap": 48503844, "fiftyTwoWeekLow": 0.55, "fiftyTwoWeekHigh": 1.93, "priceToSalesTrailing12Months": 10.498668, "fiftyDayAverage": 0.97392, "twoHundredDayAverage": 0.958505, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -6248441, "profitMargins": 0.0, "floatShares": 18530087, "sharesOutstanding": 50065900, "sharesShort": 199049, "sharesShortPriorMonth": 384094, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0044, "heldPercentInsiders": 0.26266, "heldPercentInstitutions": 0.50219, "shortRatio": 0.47, "shortPercentOfFloat": 0.0052, "impliedSharesOutstanding": 50065900, "bookValue": 0.477, "priceToBook": 2.0310273, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -62803000, "trailingEps": -1.55, "forwardEps": -0.58, "enterpriseToRevenue": -1.352, "enterpriseToEbitda": 0.1, "52WeekChange": 0.8213059, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 0.9688, "targetHighPrice": 5.0, "targetLowPrice": 4.0, "targetMeanPrice": 4.5, "targetMedianPrice": 4.5, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 61259000, "totalCashPerShare": 1.394, "ebitda": -62428000, "totalDebt": 8415000, "quickRatio": 1.611, "currentRatio": 1.665, "totalRevenue": 4620000, "debtToEquity": 40.121, "revenuePerShare": 0.104, "returnOnAssets": -0.52579, "returnOnEquity": -1.70958, "grossProfits": 4620000, "freeCashflow": -3042250, "operatingCashflow": -17648000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -6.5413203, "financialCurrency": "USD", "symbol": "XLO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1740170163, "exchange": "NMS", "messageBoardId": "finmb_365333564", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -8.6053915, "regularMarketPrice": 0.9688, "marketState": "REGULAR", "fiftyTwoWeekChangePercent": 82.130585, "earningsTimestampStart": 1743507000, "earningsTimestampEnd": 1743939000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.55, "epsForward": -0.58, "epsCurrentYear": -1.21, "priceEpsCurrentYear": -0.80066115, "fiftyDayAverageChange": -0.0051199794, "fiftyDayAverageChangePercent": -0.005257084, "twoHundredDayAverageChange": 0.010295033, "twoHundredDayAverageChangePercent": 0.01074072, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-22", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "shortName": "Xilio Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634909400000, "regularMarketChange": -0.091199934, "regularMarketDayRange": "0.9548 - 1.06", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3999077, "fiftyTwoWeekLowChange": 0.4188, "fiftyTwoWeekLowChangePercent": 0.7614545, "fiftyTwoWeekRange": "0.55 - 1.93", "fiftyTwoWeekHighChange": -0.96119994, "fiftyTwoWeekHighChangePercent": -0.49803108, "longName": "Xilio Therapeutics, Inc.", "displayName": "Xilio Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]